Vicapsys Life Sciences

(OTC) VICP

Current Price$1.46

Market Cap$47.26M

Since IPO (2018)-58%

5 Year-27%

1 Year-18%

1 Month-3%

Vicapsys Life Sciences Financials at a Glance

Market Cap

$47.26M

Revenue (TTM)

$0.00

Net Income (TTM)

$844.15K

EPS (TTM)

$-0.02

P/E Ratio

-58.63

Dividend

$0.00

Beta (Volatility)

34421.17 (High)

Dividend

$0.00

Beta (Volatility)

34421.17 (High)

Price

$1.46

Volume

Open

$1.46

Price

$1.46

Volume

Open

$1.46

Previous Close

$1.46

Daily Range

$1.46 - $1.46

52-Week Range

$0.15 - $1.77

Dividend

$0.00

Beta (Volatility)

34421.17 (High)

Price

$1.46

Volume

Open

$1.46

Previous Close

$1.46

Daily Range

$1.46 - $1.46

52-Week Range

$0.15 - $1.77

VICP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vicapsys Life Sciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Federico Luis Pier, MBA

Website

vicapsys.com

Headquarters

Cumming, GA 30024, US

VICP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

13%

Return on Assets

-71%

Earnings Yield

-1.71%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$47.26M

Shares Outstanding

32.37M

Volume

Avg. Volume

20.651

Financials (TTM)

Gross Profit

$0.00

Operating Income

$651.80K

EBITDA

$651.80K

Operating Cash Flow

$21.46K

Capital Expenditure

$3.00

Free Cash Flow

$21.46K

Cash & ST Invst.

$2.64K

Total Debt

$624.35K

Vicapsys Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$47.26M

N/A

Market Cap/Employee

$23.63M

N/A

Employees

N/A

Net Income

$181.43K

+44.5%

EBITDA

$173.18K

+40.4%

Quarterly Fundamentals

Name

Q1 2025YOY CHG

Net Cash

$573.07K

-24.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$578.95K

+25.2%

Return on Assets

-71.23%

N/A

Return on Invested Capital

13.12%

N/A

Free Cash Flow

$145.77K

+235.7%

Operating Cash Flow

$145.78K

+235.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INNMFAmplia Therapeutics Limited

INNMFAmplia Therapeutics Limited$0.09-27.69%

SNANFSona Nanotech Inc.

SNANFSona Nanotech Inc.$0.21-3.99%

ACHFFArch Biopartners Inc.

ACHFFArch Biopartners Inc.$0.32-0.64%

OTLCOncotelic Therapeutics, Inc.

OTLCOncotelic Therapeutics, Inc.$0.04-1.01%

ZIVOZIVO Bioscience, Inc.

ZIVOZIVO Bioscience, Inc.$3.55-6.58%

RLFTFMindMaze Therapeutics Holding S.A.

RLFTFMindMaze Therapeutics Holding S.A.$0.45+9.62%

PSYBFPsyBio Therapeutics Corp.

PSYBFPsyBio Therapeutics Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.91-0.01%

Questions About VICP

What is the current price of Vicapsys Life Sciences?

Vicapsys Life Sciences is trading at $1.46 per share.

What is the 52-week range for Vicapsys Life Sciences?

Over the past 52 weeks, Vicapsys Life Sciences has traded between $0.15 and $1.77.

How much debt does Vicapsys Life Sciences have?

As of the most recent reporting period, Vicapsys Life Sciences reported total debt of $578,950.

How much cash does Vicapsys Life Sciences have on hand?

Vicapsys Life Sciences reported $5,876 in cash and cash equivalents in its most recent financial results.

What is Vicapsys Life Sciences’s dividend yield?

Vicapsys Life Sciences does not currently have a dividend yield.

Vicapsys Life Sciences

Vicapsys Life Sciences Financials at a Glance

VICP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vicapsys Life Sciences

VICP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vicapsys Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VICP

What is the current price of Vicapsys Life Sciences?

What is the 52-week range for Vicapsys Life Sciences?

How much debt does Vicapsys Life Sciences have?

How much cash does Vicapsys Life Sciences have on hand?

What is Vicapsys Life Sciences’s dividend yield?

Premium Investing Services